GlassScriptPhysician profile
Katherine A Walker
NPI 1902244171
$3,155.66
in general payments reported to CMS, 2019-2025
28 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.58 · 2023: $161 · 2024: $1,417 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,019 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,019.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $781.54 | 2024-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $362.71 | 2024-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $210.06 | 2024-2025 | |
| Axonics, INC. | $189.72 | 2024 | Axonics |
| Antares Pharma, INC. | $164.49 | 2024-2025 | Xyosted |
| Ferring Pharmaceuticals INC. | $154.84 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $136.34 | 2023-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $132.24 | 2025 | |
| Myriad Genetic Laboratories, INC. | $119.85 | 2024-2025 | Prolaris |
| Astellas Pharma US INC | $114.89 | 2025 | Padcev |
| Urogen Pharma, INC. | $90.87 | 2024-2025 | |
| Endo USA, INC. | $82.29 | 2024-2025 | Xiaflex, Aveed, Edex |
| Pfizer INC. | $81.02 | 2024-2025 | |
| Boston Scientific Corporation | $66.67 | 2023 | |
| Novartis Pharmaceuticals Corporation | $60.85 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $51.50 | 2024-2025 | Eligard, Jatenzo |
| Telix Pharmaceuticals | $45.47 | 2024-2025 | Illuccix |
| Merck Sharp & Dohme LLC | $44.16 | 2025 | Keytruda, Keytruda Qlex |
| Dentsply Ih Ab | $37.86 | 2025 | Lofric |
| Bioprotect Medical, INC. | $34.18 | 2025 | Bioprotect Balloon Implant System |
| Lantheus Medical Imaging, INC. | $28.85 | 2024 | |
| Immunitybio, INC. | $28.50 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $26.19 | 2025 | |
| Tempus Ai, INC | $25.25 | 2024 | |
| 180 Medical, INC. | $24.58 | 2019 | |
| Abc Home Medical Supply, INC. | $23.10 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $19.98 | 2025 | |
| Bluewind Medical | $17.66 | 2025 | Revi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.